This preliminary observation on only a small number of subjects needs to be confirmed in prospective clinical trials before conclusions about the predictive potential of [68Ga]Ga-NOTA-anti-CD206-sdAb PET in cancer can be made. This evidence concerns the gene MRC1 and cancer.